T1	Participants 108 145	patients with gastrointestinal cancer
T2	Participants 417 454	patients with gastrointestinal cancer
T3	Participants 747 818	512 patients with gastrointestinal cancer included in the TACTIC study.
T4	Participants 1435 1471	patients with gastrointestinal cance
